GC147 Heart Failure And Cyanosis In Children Acyanotic And Cyanotic Congenital Heart Disease - Part 1
Congenital heart diseases are classified as acyanotic lesions (e.g., VSD, ASD, PDA) with left-to-right shunts causing heart failure, and cyanotic lesions (e.g., Tetralogy of Fallot, TGA) with right-to-left shunts producing systemic desaturation and cyanosis.
Heart Failure in Children: Acyanotic & Cyanotic Congenital Heart Disease — Part 1
Big Idea: This lecture, delivered by Professor Yiu-fai Cheung (Division of Paediatric Cardiology, HKU), focuses on paediatric heart failure — a fundamentally different entity from adult heart failure. In adults, heart failure is usually caused by myocardial dysfunction (e.g., ischaemic heart disease destroying muscle). In children, the heart muscle is often perfectly normal — the problem is structural congenital heart defects that impose excessive workload (volume or pressure overload) on an otherwise healthy myocardium. This distinction is the conceptual backbone of the entire lecture. [1]
Learning Objectives (from the lecture overview slide):
Concept of 'heart failure' — Important categories of structural congenital heart lesions that cause heart failure in neonates and infants — 'Duct-dependent' systemic circulation — Management of heart failure [1]
1. The Concept of Paediatric Heart Failure
"The pathophysiologic state in which the heart fails to pump blood at a rate to meet the demand of the body." [1]
This is a supply vs demand mismatch. The lecture emphasises two distinct mechanisms: [1]
| Mechanism | Explanation | Predominant Age Group |
|---|---|---|
| Dysfunction of the heart | Intrinsic problem with contractility (myocardium itself is sick) | More common in adults; also neonates (myocarditis, cardiomyopathy, ischaemia) and older children |
| Cardiac overload (pressure or volume overload) | Heart muscle contracts normally, but faces an abnormal haemodynamic burden from structural CHD | Much more common in children |
Key Conceptual Point — The Patient A vs Patient B Slide
The lecture opens with two echocardiogram video examples to contrast preserved and impaired contractility. A single still frame cannot establish contractility; that requires watching wall motion through the cardiac cycle and measuring ventricular function. The teaching point is that impaired contractility is not the only cause of heart failure - structural lesions can produce symptomatic pressure or volume overload despite preserved systolic function. [1][2]
Why this matters from first principles:
- In an adult with IHD, myocytes die → contractility drops → forward failure + backward congestion.
- In a baby with a large VSD, the heart muscle is fine, but blood keeps shunting left-to-right → pulmonary overcirculation → volume overloads the LA and LV → heart failure despite normal or even hyperdynamic contraction.
In adults, heart failure is predominantly due to dysfunction of the heart. In children, heart failure is predominantly due to overloading of the heart. [1]
This is a crucial exam discriminator. If asked "What is the most common mechanism of heart failure in paediatric patients?", the answer is volume/pressure overload from congenital structural heart defects, not myocardial dysfunction.
The adult-versus-child pie charts on the slide are qualitative teaching graphics, not prevalence data. They show the dominant mechanisms conceptually and should not be quoted as numerical epidemiology.
2. Clinical Presentation: How Do Infants and Children with Heart Failure Present?
Breathlessness, especially on exertion — Poor feeding — Excessive sweating — Failure to thrive — Recurrent chest infection — Exercise incapacity in older children [1]
Why each symptom occurs — explained from first principles:
| Symptom | Mechanism | Clinical Correlation |
|---|---|---|
| Breathlessness on exertion | Pulmonary congestion from elevated LA pressure → interstitial oedema → reduced lung compliance → increased work of breathing | In infants, "exertion" = feeding. A baby who takes 20 minutes to finish 30 mL of milk and gets breathless is "exerting" maximally |
| Poor feeding | Combination of breathlessness during feeds + increased metabolic demand + splanchnic hypoperfusion | Infants cannot tell you they're breathless; they just stop feeding or take very small volumes |
| Excessive sweating | Sympathetic activation (compensatory mechanism to maintain CO) → diaphoresis, especially during feeds | Sweating during feeds is a classic history clue in paediatric heart failure |
| Failure to thrive | Increased metabolic demand from tachycardia + tachypnoea + poor caloric intake (feeds poorly) → negative energy balance | Weight faltering is often the presenting complaint that leads to discovery of CHD |
| Recurrent "chest infections" | Pulmonary overcirculation and congestion can repeatedly mimic bronchiolitis or pneumonia; a true intercurrent infection can also precipitate decompensation | Recurrent or treatment-resistant respiratory labels plus poor growth should trigger reassessment for CHD rather than an assumption that every episode is infection |
| Exercise incapacity | Relevant for older children; inability to keep up with peers during sports | Less relevant in infancy since infants don't exercise formally |
2.2 Signs (Physical Examination)
The lecture categorises signs into three groups: [1]
Tachypnoea — Subcostal insucking — Wheezing in infants [1]
| Sign | Why It Happens |
|---|---|
| Tachypnoea | Elevated LA pressure → increased pulmonary venous pressure → transudation into interstitium → stiff lungs → compensatory rapid shallow breathing |
| Subcostal insucking (retractions) | Increased work of breathing against non-compliant, congested lungs → accessory muscle use. In infants, the chest wall is very compliant, so retractions are prominent |
| Wheezing in infants | Bronchial oedema from pulmonary congestion + compression of small airways by distended pulmonary vessels. This is often mistaken for "bronchiolitis" or "asthma" — a classic trap! |
Common Trap — Cardiac Wheeze Mimicking Respiratory Disease
Hepatomegaly — Distension of neck veins (not obvious in small children) — Peripheral oedema (rare in the absence of cardiac dysfunction) [1]
| Sign | Why It Differs From Adults |
|---|---|
| Hepatomegaly | A useful sign of right-sided or biventricular congestion. Interpret liver size for age, respiratory phase and clinical context rather than relying on one universal centimetre cut-off [3] |
| JVP distension | Anatomically difficult to assess in infants because of short, fat necks. Not a reliable sign in small children [1] |
| Peripheral oedema | Rare in the absence of cardiac dysfunction [1]. In children with structural overload (e.g., large VSD), peripheral oedema is uncommon. If you see significant peripheral oedema in a child with heart failure, think about myocardial dysfunction (myocarditis, cardiomyopathy) or nephrotic syndrome |
Tachycardia — Cardiomegaly [1]
- Tachycardia: Sympathetic activation → increased heart rate to maintain cardiac output (CO = HR × SV). This is one of the earliest signs.
- Cardiomegaly: Chronic volume overload can cause chamber dilation and a displaced apex. On CXR, apparent heart size is strongly affected by projection, rotation, inspiration and the infant thymus; do not turn the lecture's approximate cardiothoracic-ratio thresholds into stand-alone diagnostic cut-offs.
Cool extremities — Prolonged capillary refill — Decreased pulse volume — These signs are unusual, only when decompensated [1]
Why this is "unusual": In most paediatric heart failure from structural overload, compensatory mechanisms (tachycardia, ventricular dilation, sympathetic drive) maintain forward output for a long time. It's only when these mechanisms are overwhelmed — or when the duct closes in duct-dependent lesions — that you get frank low cardiac output.
When you DO see these signs, the child is critically ill and needs urgent intervention.
3. Causes of Paediatric Heart Failure — Organised by Age
This is the core organisational framework of the lecture. The aetiology differs dramatically by age:
1) Left ventricular outflow tract obstruction — 2) Myocardial dysfunction — 3) Abnormalities of heart rate or rhythm — 4) Extra-cardiac causes [1]
| Category | Specific Causes | Key Features |
|---|---|---|
| LVOT obstruction | Coarctation of the aorta, Interrupted aortic arch, Critical aortic stenosis, Aortic atresia (HLHS) [1] | Present in first days of life when ductus arteriosus closes → sudden loss of systemic perfusion → shock |
| Myocardial dysfunction | Transient myocardial ischaemia, Myocarditis, Cardiomyopathy [1] | These cause true pump failure with reduced contractility |
| Abnormal heart rate | Supraventricular tachycardia (SVT), Complete heart block (CHB) [1] | SVT: rate too fast → inadequate diastolic filling → ↓CO. CHB: rate too slow → ↓CO despite normal SV |
| Extra-cardiac causes | Sepsis, Asphyxia, Hypocalcaemia, Anaemia [1] | Systemic disturbances causing secondary ventricular dysfunction. Sepsis → myocardial depressant factors. Asphyxia → myocardial ischaemia. Hypocalcaemia → impaired excitation-contraction coupling |
Reading the ECG slide: the SVT examples show a regular, very rapid narrow-complex tachycardia with no clearly separable sinus P waves. The complete heart block tracing shows AV dissociation: atrial P waves march through independently of a much slower ventricular escape rhythm. In a sick neonate, rhythm recognition is followed by haemodynamic assessment and age/weight-appropriate paediatric resuscitation guidance - the image alone does not determine treatment. [1]
Why Hypocalcaemia Causes Heart Failure
3.2 Left Ventricular Outflow Tract (LVOT) Obstruction — In Detail
This section is extensively covered in the lecture and is extremely high-yield.
1) Coarctation or interruption of the aorta — 2) Critical aortic stenosis — 3) Aortic atresia (hypoplastic left heart syndrome) [1]
Coarctation of the aorta is a localised narrowing of the aorta, typically at or near the site of the ductus arteriosus (juxtaductal). [1]
What the images show: the cartoon and angiogram localise a discrete juxtaductal shelf/narrow segment. In the duct-dependent diagram, the duct joins the descending aorta beyond that narrowing, explaining how pulmonary-artery blood can temporarily sustain distal systemic perfusion. [1]
Haemodynamics from first principles:
- In utero: The ductus arteriosus is open → blood bypasses the coarctation via the duct → baby is fine.
- After birth: The ductus begins to close (physiologically by day 1–2) → the narrow segment is now the only pathway for systemic blood flow to the lower body → if the coarctation is severe ("critical"), the LV cannot push blood past it → acute LV failure + lower body ischaemia.
Presentation:
- Days 2–7 of life (as duct closes): shock, poor perfusion, weak/absent femoral pulses, metabolic acidosis, oliguria/anuria
- Upper limb hypertension with lower limb hypotension (4-limb BP discrepancy)
Importance of pulse examination — Femoral pulse in particular [1]
MUST-KNOW Clinical Sign
Weak or delayed femoral pulses relative to the upper limbs should raise urgent concern for coarctation. Check femoral pulses, upper- and lower-limb blood pressures, perfusion and pre-/post-ductal saturations, but remember that an open duct can temporarily mask pulse and pressure differences. A normal pulse-ox screen or initially palpable femorals do not reliably exclude CoA. [1][3][10]
Interrupted aortic arch is the most severe form of aortic arch obstruction — there is a complete discontinuity in the aortic arch. [1]
Visual distinction from CoA: the specimen and angiogram show a true gap between the proximal arch and descending aorta, rather than an extremely tight but continuous lumen. The duct then becomes the only route to the downstream aorta. [1]
- The lower body is entirely dependent on the ductus arteriosus for systemic blood flow.
- When the duct closes → catastrophic circulatory collapse.
- Often associated with DiGeorge syndrome (22q11 deletion) — look for associated features.
Critical aortic stenosis — the aortic valve cusps are thickened and fused, creating severe obstruction to LV outflow from birth. [1]
The gross-specimen comparison contrasts thin, mobile, separated cusps with a thickened fused valve. The catheter image shows a narrow transvalvar jet/outflow channel above the LV. [1]
- If severe enough, the LV cannot generate adequate systemic output → LV failure → duct-dependent systemic circulation.
- Management: balloon dilation (catheter-based) or surgical repair. [1]
Aortic atresia (Hypoplastic Left Heart Syndrome) — the left ventricle, mitral valve, and aortic valve are severely underdeveloped or atretic. [1]
The diagram and specimen make the scale mismatch visible: the LV and ascending aorta are diminutive while the RV and pulmonary trunk dominate; systemic output reaches the aorta through the duct. [1]
- There is essentially no functional left ventricle → the entire systemic circulation depends on the RV pumping blood through the PDA to the systemic circuit.
- When the duct closes → immediate circulatory collapse and death without intervention.
- Management: staged surgical palliation (Norwood procedure) or heart transplantation.
Concept of 'ductal-dependent systemic circulation' — Prostaglandin E1/E2 [1]
This is one of the most important concepts in paediatric cardiology for exams and clinical practice.
What does "duct-dependent systemic circulation" mean?
- In lesions where the LVOT is critically obstructed (CoA, IAA, critical AS, HLHS), the lower body (and sometimes the entire systemic circulation) receives blood flow via the ductus arteriosus — blood travels from the pulmonary artery → through the PDA → into the descending aorta.
- If the duct closes (which it naturally does within 24–48 hours after birth), systemic perfusion is lost → shock, organ failure, death.
Management - Prostaglandin E1 (PGE1):
- Current emergency practice uses IV alprostadil (PGE1) to maintain or restore ductal patency as a bridge to catheter or surgical treatment. The slide's "PGE1/E2" wording is lecture-era shorthand, not an invitation to choose either drug interchangeably. [9]
- This is a life-saving bridge while the baby is stabilised and prepared for corrective surgery or catheter intervention.
| Feature | Details |
|---|---|
| Drug | PGE1 (alprostadil) continuous IV infusion under neonatal/cardiology supervision |
| Mechanism | Relaxes ductal smooth muscle → prevents/reverses ductal closure |
| Side effects | Apnoea (important — may need ventilatory support), fever, diarrhoea, jitteriness, flushing |
| When to give | If duct-dependent CHD is strongly suspected in a critically ill neonate, stabilise ABCs, involve neonatal/cardiology retrieval immediately and start PGE1 without waiting for a delayed definitive scan [9] |
Life-Saving Principle
A shocked neonate with weak femoral pulses is a time-critical emergency. Support airway, breathing and circulation, check glucose/sepsis and other reversible causes, obtain urgent expert help and echocardiography, and start PGE1 promptly when a duct-dependent lesion is suspected. Alprostadil commonly causes apnoea and hypotension, so airway and ventilatory support must be immediately available. [1][5][9]
Differential cyanosis and clubbing in duct-dependent systemic circulation:
- In CoA/IAA with PDA: the upper body receives oxygenated blood from the LV via the aortic arch. The lower body receives mixed (deoxygenated) blood via the PDA from the RV.
- Result: upper body pink, lower body cyanotic = differential cyanosis. [6][3]
- Over time (if chronic), differential clubbing develops (toes but not fingers).
3.4 Heart Failure in Infants (Weeks to Months of Life)
Large left-to-right shunts: Ventricular septal defect, Atrioventricular septal defect, Persistent arterial duct [1]
Later onset of symptoms (as compared to left ventricular outflow obstructive lesions) [1]
Why is the onset later?
- At birth, pulmonary vascular resistance (PVR) is high (similar to systemic vascular resistance) → even with a structural defect allowing communication between systemic and pulmonary circulations, there is little net shunt.
- Over the first 2–3 months of life, PVR falls physiologically (as the thick-walled fetal pulmonary arterioles remodel) → the pressure difference between the systemic and pulmonary circuits widens → blood shunts left-to-right through the defect → pulmonary overcirculation → heart failure symptoms emerge.
- This is why babies with large VSDs or PDAs typically present at 6–8 weeks of age with symptoms of heart failure, not at birth.
Increased pulmonary blood flow → Increased pulmonary venous return → Volume overloading of left atrium and left ventricle (except atrial septal defect) [1]
Step-by-step mechanism:
- Blood shunts from left (high pressure) to right (low pressure) through the defect
- Pulmonary blood flow increases (Qp:Qs ratio rises above 1:1)
- More blood returns to the left atrium via pulmonary veins
- LA and LV become volume-overloaded → LA dilation, LV dilation
- Increased LV end-diastolic pressure → elevated LA pressure → pulmonary venous congestion → pulmonary oedema → tachypnoea, feeding difficulties, failure to thrive
- If uncorrected: chronic pulmonary overcirculation → pulmonary vascular disease → irreversible pulmonary hypertension → Eisenmenger syndrome (reversal of shunt)
Reading the slide's CXR and echo: the radiograph combines cardiomegaly with pulmonary plethora, while the echo demonstrates enlarged left-sided receiving chambers. Together these support a haemodynamically important high-flow shunt; neither image alone defines defect size or operability. [1]
VSD is the most common congenital heart defect (~30% of all CHD). [5]
The cartoon and colour-Doppler frame localise the opening in the ventricular septum and show a high-velocity jet crossing it. Doppler colour demonstrates turbulent flow, but direction depends on the displayed colour scale; size, gradient and chamber effects must be assessed on the full echo rather than inferred from one still. [1]
- Small VSD: Restrictive → small shunt → loud pansystolic murmur (high-velocity jet) → usually asymptomatic → may close spontaneously
- Large VSD: Non-restrictive → large L-to-R shunt → heart failure by 6–8 weeks → soft or mid-systolic murmur (low-velocity, wide-open defect) → requires surgical closure
AVSD involves a defect in the endocardial cushion → single AV valve spanning both ventricles + atrial and ventricular level communication. [1]
The specimen/cartoon shows loss of the normal central cardiac "crux" and a bridging common AV-valve morphology - the visual clue that this is more than an isolated ASD plus VSD. [1]
- Strongly associated with Down syndrome (trisomy 21)
- Complete AVSD: both atrial and ventricular components + common AV valve → large L-to-R shunt + AV valve regurgitation → early heart failure
- Management: surgical repair at 3–6 months [5]
Persistent arterial duct (PDA) = failure of the ductus arteriosus to close after birth. [1]
The diagram places the duct between the descending aorta and pulmonary artery. After the normal postnatal fall in PVR, pressure drives aorta-to-PA flow, explaining pulmonary overcirculation and left-heart volume loading. [1]
- Blood shunts from aorta (high pressure) to pulmonary artery (low pressure) → pulmonary overcirculation
- Classic murmur: continuous "machinery" murmur at the left infraclavicular area
- Common in premature infants and associated with congenital rubella
- Management is physiology- and gestation-specific. In a preterm infant with a haemodynamically significant PDA, targeted pharmacologic closure may use ibuprofen or indomethacin under a neonatal protocol; not every PDA should be treated. Catheter or surgical closure is selected by size, anatomy and clinical effect. [5]
ASD is an uncommon cause of heart failure in infancy and childhood — volume overloading of the right atrium and right ventricle [1]
Shunting from LA to RA → Increased flow through tricuspid valve during diastole → Volume overloading of right ventricle [1]
Why is ASD different?
- In VSD/AVSD/PDA, the shunt volume-loads the left heart (LA and LV).
- In ASD, the shunt goes from LA → RA → RV → pulmonary artery. The left heart is NOT volume-overloaded; it is the right heart that bears the burden.
- Because the RV is very compliant, it can accommodate the extra volume for years or decades without symptoms → hence ASD rarely causes heart failure in childhood.
- ASD typically presents in adulthood (30s–40s) with symptoms or is discovered incidentally as a fixed split S2 + soft ejection systolic murmur at LUSB.
The ASD flow diagram makes the chamber sequence explicit: LA-to-RA flow increases diastolic tricuspid inflow, then dilates the RA/RV and pulmonary artery. This is why the receiving chamber pattern differs from VSD/PDA. [1]
| Lesion | Chamber Overloaded | Timing of HF |
|---|---|---|
| VSD, AVSD, PDA | LA + LV | 6–8 weeks (when PVR falls) |
| ASD | RA + RV | Rarely in childhood; usually adulthood |
Myocardial disease: Myocarditis, Cardiomyopathy (primary, secondary) — Unoperated structural heart defects — Certain repaired or palliated congenital heart defects [1]
In older children, the spectrum shifts back toward myocardial dysfunction being a more common cause:
| Cause | Examples |
|---|---|
| Myocarditis | Viral (Coxsackie B, adenovirus), post-infectious |
| Primary cardiomyopathy | Dilated, hypertrophic, restrictive |
| Secondary cardiomyopathy | Iron overload (thalassaemia major), post-chemotherapy (anthracyclines), neuromuscular disease (Duchenne muscular dystrophy) |
| Unoperated CHD | Late presentation of previously unrecognised defects |
| Repaired/palliated CHD | Ventricular dysfunction after surgery (e.g., systemic RV in Fontan circulation) |
4. Management of Paediatric Heart Failure
1) Identification of the cause and precipitating factors — 2) Tackling of precipitating factors — 3) General supportive management — 4) Medical therapy of heart failure (diuretics, digoxin, ACEI, carvedilol) — 5) Treatment of underlying cause, if possible, by surgical or catheter intervention — 6) Mechanical circulatory support and heart transplantation [1]
This is the lecture-era list, not a universal prescription. Paediatric HF is heterogeneous, and the evidence base is smaller than in adult HF. In a large structural shunt, for example, diuresis and nutritional support may temporise symptoms while definitive repair treats the cause; digoxin, ACE inhibitors and beta-blockers are lesion-, ventricular- and specialist-dependent rather than automatic additions. [8]
| Step | Details |
|---|---|
| 1. Identify cause | History, examination, CXR, ECG, echocardiogram |
| 2. Tackle precipitating factors | Treat infection, correct anaemia, address arrhythmia, correct electrolytes |
| 3. General supportive | Individualised fluid and nutrition plan, respiratory support when indicated, treatment of infection/anaemia/electrolyte disturbance and close perfusion/urine-output monitoring |
| 4. Medical therapy | Diuretics can relieve congestion. Other agents (digoxin, ACE inhibition, beta-blockade or advanced HF therapy) depend on anatomy, ventricular physiology, blood pressure, renal function and specialist assessment - avoid importing an adult-HF bundle uncritically [8] |
| 5. Definitive treatment | Surgical repair (e.g., VSD closure, CoA repair) or catheter intervention (e.g., balloon dilation of critical AS, device closure of ASD/PDA) |
| 6. Advanced therapies | ECMO, ventricular assist device (VAD), heart transplantation |
The slide states initial stabilisation by PGE1/E2 followed by corrective surgery or catheter intervention. [1] In current practice this means PGE1 (alprostadil) as above. [9]
- Coarctation / Interrupted aortic arch: Surgical repair of the narrowed/interrupted segment [1]
- Critical aortic stenosis: Balloon dilation or surgical repair [1]
- HLHS: Staged surgical palliation (Norwood → Glenn → Fontan) or transplantation
The balloon-valvuloplasty sequence shows a wire/catheter crossing the stenotic aortic valve, balloon inflation across the valve, then deflation with a wider outflow channel. It is a specialist, anatomy-dependent intervention; residual/recurrent stenosis and aortic regurgitation require surveillance. [1]
Surgical closure of VSD and PDA — Device closure of ASD and PDA [1]
| Method | Applicable Lesions | Details |
|---|---|---|
| Surgical closure | VSD, PDA, AVSD | Open-heart surgery with CPB; gold standard for large defects |
| Device closure (catheter-based) | Suitable ASD (secundum type), suitable PDA | Less invasive, shorter recovery; not suitable for all defects (e.g., primum ASD requires surgical repair) |
The occluder-device images are anatomy lessons, not generic closure instructions: the two discs sit on either side of a suitable secundum ASD, while a PDA device plugs the ductal channel. Defect rims, size, relation to adjacent structures and patient size determine suitability. [1]
The adjacent operative cartoons show a VSD closed with a patch and a PDA surgically interrupted. Their purpose is to contrast direct operative closure with catheter occlusion, not to imply that every defect has both options. [1]
4.4 Mechanical Circulatory Support
ECMO [1] — Provides temporary cardiopulmonary support. The slide contrasts veno-arterial (VA) ECMO, which can support circulation and gas exchange in cardiogenic shock, with veno-venous (VV) ECMO, which supports gas exchange but does not directly replace cardiac output. Mode and cannulation are specialist decisions.
Ventricular Assist Device — Concept of Bridging [1]
- VADs mechanically augment ventricular output.
- Used as a bridge to transplantation (keeps the child alive while waiting for a donor heart) or bridge to recovery (supports the ventricle while myocardial function recovers, e.g., in myocarditis).
- In the slide schematic, an inflow cannula drains the failing ventricle and the pump returns blood to the aorta. The collage also shows that paediatric systems may be paracorporeal or implantable and size-specific; a VAD is a bridge strategy, not correction of the underlying lesion. [1]
5. Integration with Related Material
From supporting sources, the overall classification of CHD by physiology is useful for context: [5][6][7]
| Category | Physiology | Examples |
|---|---|---|
| Acyanotic — L-to-R shunts | Volume overload → HF at 2–3 months | VSD, ASD, PDA, AVSD |
| Acyanotic — Outflow obstruction (sick neonate) | Pressure overload → shock when duct closes | CoA, critical AS, HLHS, IAA |
| Acyanotic — Outflow obstruction (well child) | Mild-moderate obstruction | PS, mild AS |
| Cyanotic — R-to-L shunts | Decreased pulmonary flow → cyanosis | TOF, PA, critical PS |
| Cyanotic — Common mixing | Mixing of oxygenated and deoxygenated blood | TGA, TAPVD, truncus arteriosus, univentricular heart |
Though primarily covered in Part 2, it connects to this lecture:
- Historical method: very high inspired oxygen for about 10 minutes, followed by a preductal arterial PaO₂.
- Why it is historical: response thresholds overlap among parenchymal lung disease, persistent pulmonary hypertension and CHD, while early echocardiography defines anatomy directly. Hyperoxia testing is therefore no longer widely practised when echo is available. [11]
- Safety correction: do not withhold oxygen or resuscitation from a hypoxaemic/shocked neonate because CHD is possible. Provide titrated respiratory support while urgently assessing pre-/post-ductal saturations, perfusion, blood gas, lung/sepsis causes and cardiac anatomy. [10][11]
- Central cyanosis is traditionally described as becoming apparent at roughly 3-5 g/dL of reduced Hb, but there is no dependable universal saturation cut-off; appearance varies with haemoglobin, perfusion, lighting and skin pigmentation.
- Anaemia can mask cyanosis and polycythaemia can make it more apparent; use objective oxygenation assessment rather than colour alone. [10]
- Polycythaemia can exaggerate cyanosis [6]
| Syndrome | Associated CHD |
|---|---|
| Down syndrome (trisomy 21) | AVSD, VSD |
| Turner syndrome (45,X) | CoA, bicuspid AV |
| DiGeorge syndrome (22q11.2 del) | IAA, TOF, truncus arteriosus |
| Williams syndrome | Supravalvular AS |
| Noonan syndrome | ASD, PS |
| Marfan syndrome | MR, AR, MVP |
| Congenital rubella | PDA |
| Maternal SLE (anti-Ro/La antibodies) | Congenital complete heart block |
6. Exam Intelligence
| Question Type | Example Stem |
|---|---|
| MCQ | A 5-day-old neonate presents with poor feeding, tachypnoea, and absent femoral pulses. What is the most likely diagnosis? → Coarctation of the aorta |
| MCQ | Which of the following congenital heart defects causes volume overloading of the RIGHT ventricle? → ASD (not VSD, which overloads the LV) |
| SAQ | Describe the concept of duct-dependent systemic circulation and explain the role of PGE1 |
| SAQ | List 4 causes of heart failure in neonates |
| Minicase | A 6-week-old infant presents with tachypnoea, excessive sweating during feeds, and failure to thrive. On examination: tachycardia, hepatomegaly, pansystolic murmur at LLSB. Discuss the most likely diagnosis and management → Large VSD with heart failure |
| OSCE | Demonstrate palpation of femoral pulses in a neonate and explain why |
Common Exam Traps
- Confusing the timing of presentation: LVOT obstruction → presents in first days of life (duct-dependent). Large L-to-R shunts → present at 6–8 weeks (after PVR drops).
- Assuming ASD causes heart failure in childhood: ASD is an uncommon cause of heart failure in infancy and childhood — it overloads the RV, which tolerates volume well.
- Forgetting to check femoral pulses: Weak/delayed femorals and upper-lower BP differences support CoA, but neither pulses nor pulse-ox screening excludes it while the duct remains open.
- Confusing peripheral oedema with paediatric heart failure: Peripheral oedema is rare in the absence of cardiac dysfunction in children — it suggests myocardial disease, not just structural overload.
- Withholding oxygen from a sick neonate because CHD is possible: use titrated oxygen/ventilation when clinically required while expediting PGE1 and echo; avoid both untreated hypoxaemia and indiscriminate hyperoxia.
| Feature | VSD | ASD | PDA |
|---|---|---|---|
| Chamber overloaded | LA + LV | RA + RV | LA + LV |
| Timing of HF | 6–8 weeks | Rarely childhood | 6–8 weeks |
| Classic murmur | Pansystolic at LLSB | Fixed split S2 + ESM at LUSB | Continuous machinery murmur at left infraclavicular |
| Spontaneous closure | Small ones can | No (except PFO) | Indomethacin/ibuprofen in prems |
High Yield Summary
-
Paediatric heart failure is fundamentally different from adult heart failure.
- In children, the most common mechanism is cardiac overload from congenital structural defects (volume or pressure overload), NOT myocardial dysfunction.
-
Age-based causes
- Neonates: LVOT obstruction (CoA, IAA, critical AS, HLHS) → duct-dependent → PGE1; myocardial dysfunction; arrhythmia; extra-cardiac causes
- Infants (6–8 weeks): Large L-to-R shunts (VSD, AVSD, PDA) as PVR falls
- Older children: Myocardial disease (myocarditis, cardiomyopathy), unoperated/repaired CHD
-
Key clinical points
- Cardinal triad in infants: tachypnoea + tachycardia + hepatomegaly
- Always compare femoral with upper-limb pulses, but remember an open duct can mask CoA
- ASD rarely causes heart failure in childhood (overloads RV, not LV)
- Peripheral oedema is rare without cardiac dysfunction
- Wheezing in infants can be cardiac, not respiratory
-
Management
- Identify cause → treat precipitating factors → individualised supportive/medical therapy → lesion-specific surgical or catheter intervention → ECMO/VAD/transplant for selected refractory cases.
-
Emergency
- Suspected duct-dependent systemic collapse → ABC stabilisation + expert neonatal/cardiology help + prompt PGE1 + urgent echo.
Active Recall - Lecture Notes
[1] Lecture slides: GC 147. Heart failure and cyanosis in children acyanotic and cyanotic congenital heart disease - Part 1.pdf (all slides p1–p43) [2] Paediatrics lecture notes: Block C - Heart failure and cyanosis in children: acyanotic and cyanotic congenital heart disease.pdf (p1) [3] Senior notes: Adrian Lui Pediatrics Notes.pdf (p185, p197) [4] Paediatrics lecture notes: Evaluation of wheezing in infants and children - UpToDate.pdf [5] Senior notes: Maksim Paediatric Notes.pdf (p55–p60) [6] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p267, p279, p290) [7] Senior notes: Ryan Ho Cardiology.pdf (p184, p186, p187) [8] American Heart Association. Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement. 2024. https://professional.heart.org/en/guidelines-statements/evaluation-and-management-of-chronic-heart-failure-in-children-and-adolescentscir0000000000001245 [9] US National Library of Medicine DailyMed. PROSTIN VR PEDIATRIC (alprostadil) prescribing information. Current label. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=930f8c02-46a8-4cff-a484-660468ab23c3 [10] American Academy of Pediatrics. Newborn Screening for Critical Congenital Heart Disease: A New Algorithm and Other Updated Recommendations. Pediatrics. 2025;155(1):e2024069667. https://doi.org/10.1542/peds.2024-069667 [11] Lakshminrusimha S, Keszler M. Persistent Pulmonary Hypertension of the Newborn. NeoReviews. 2015;16(12):e680-e692. https://doi.org/10.1542/neo.16-12-e680
GC146 A Jaundiced Child
A jaundiced child presents with yellow discoloration of the skin and sclera due to elevated bilirubin, requiring systematic evaluation to distinguish physiological, hemolytic, hepatocellular, or obstructive causes across different age groups.
GC147 Heart Failure And Cyanosis In Children Acyanotic And Cyanotic Congenital Heart Disease - Part 2
Cyanotic congenital heart diseases are structural cardiac defects involving right-to-left shunting of deoxygenated blood into the systemic circulation, resulting in hypoxemia and clinically apparent cyanosis in children.